Green Alpha Advisors, LLC Crispr Therapeutics Ag Transaction History

Green Alpha Advisors, LLC

$112 Million
Q4 2024

A detailed history of Green Alpha Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 24,629 shares of CRSP stock, worth $1.08 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

24,629

Previous 19,158 28.56%

Holding current value

$1.08 Million

Previous $900,000 7.67%

% of portfolio

0.87%

Previous 0.73%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$38.65 - $55.15 $211,454 - $301,725	5,471 Added 28.56%	24,629 $969,000
Q3 2024 Oct 07, 2024	SELL	$44.62 - $62.75 $21,372 - $30,057	-479 Reduced 2.44%	19,158 $900,000
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $374,513 - $499,009	-7,319 Reduced 27.15%	19,637 $1.06 Million
Q1 2024 Apr 09, 2024	BUY	$60.67 - $89.12 $145,972 - $214,422	2,406 Added 9.8%	26,956 $1.84 Million
Q4 2023 Jan 04, 2024	SELL	$38.62 - $72.18 $398,944 - $745,619	-10,330 Reduced 29.62%	24,550 $1.54 Million
Q3 2023 Oct 10, 2023	BUY	$45.39 - $59.0 $23,012 - $29,913	507 Added 1.47%	34,880 $1.58 Million
Q2 2023 Jul 06, 2023	BUY	$43.47 - $67.77 $77,811 - $121,308	1,790 Added 5.49%	34,373 $1.93 Million
Q1 2023 Apr 06, 2023	BUY	$41.0 - $56.12 $79,417 - $108,704	1,937 Added 6.32%	32,583 $1.47 Million
Q4 2022 Jan 12, 2023	BUY	$39.19 - $65.67 $124,624 - $208,830	3,180 Added 11.58%	30,646 $0
Q3 2022 Oct 14, 2022	SELL	$61.1 - $83.78 $12.3 Million - $16.8 Million	-200,820 Reduced 87.97%	27,466 $1.8 Million
Q2 2022 Jul 08, 2022	BUY	$43.23 - $73.83 $8.77 Million - $15 Million	202,753 Added 794.08%	228,286 $13.9 Million
Q1 2022 Apr 19, 2022	BUY	$53.19 - $79.24 $445,413 - $663,555	8,374 Added 48.8%	25,533 $1.6 Million
Q4 2021 Jan 12, 2022	BUY	$70.09 - $111.29 $156,791 - $248,955	2,237 Added 14.99%	17,159 $1.3 Million
Q3 2021 Oct 12, 2021	BUY	$110.2 - $156.64 $243,982 - $346,800	2,214 Added 17.42%	14,922 $1.67 Million
Q2 2021 Jul 22, 2021	BUY	$100.84 - $161.89 $596,367 - $957,417	5,914 Added 87.05%	12,708 $2.06 Million
Q1 2021 Jul 22, 2021	BUY	$110.72 - $210.04 $48,938 - $92,837	442 Added 6.96%	6,794 $828,000
Q4 2020 Jul 22, 2021	BUY	$79.67 - $173.23 $506,063 - $1.1 Million	6,352 New	6,352 $973,000

Others Institutions Holding CRSP

# of Institutions

487

Shares Held

64.1M

Call Options Held

1.64M

Put Options Held

1.93M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.42B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.

Account

Green Alpha Advisors, LLC Crispr Therapeutics Ag Transaction History